CoChat

Oral Streptococci Utilize a Siglec-Like Domain of Serine-Rich Repeat Adhesins to Preferentially Target Platelet Sialoglycans in Human Blood

Open access

The DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.

Abstract

Damaged cardiac valves attract blood-borne bacteria, and infective endocarditis is often caused by viridans group streptococci. While such bacteria use multiple adhesins to maintain their normal oral commensal state, recognition of platelet sialoglycans provides an intermediary for binding to damaged valvular endocardium. We use a customized sialoglycan microarray to explore the varied binding properties of phylogenetically related serine-rich repeat adhesins, the GspB, Hsa, and SrpA homologs from Streptococcus gordonii and Streptococcus sanguinis species, which belong to a highly conserved family of glycoproteins that contribute to virulence for a broad range of Gram-positive pathogens. Binding profiles of recombinant soluble homologs containing novel sialic acid-recognizing Siglec-like domains correlate well with binding of corresponding whole bacteria to arrays. These bacteria show multiple modes of glycan, protein, or divalent cation-dependent binding to synthetic glycoconjugates and isolated glycoproteins in vitro. However, endogenous asialoglycan-recognizing clearance receptors are known to ensure that only fully sialylated glycans dominate in the endovascular system, wherein we find these particular streptococci become primarily dependent on their Siglec-like adhesins for glycan-mediated recognition events. Remarkably, despite an excess of alternate sialoglycan ligands in cellular and soluble blood components, these adhesins selectively target intact bacteria to sialylated ligands on platelets, within human whole blood. These preferred interactions are inhibited by corresponding recombinant soluble adhesins, which also preferentially recognize platelets. Our data indicate that circulating platelets may act as inadvertent Trojan horse carriers of oral streptococci to the site of damaged endocardium, and provide an explanation why it is that among innumerable microbes that gain occasional access to the bloodstream, certain viridans group streptococci have a selective advantage in colonizing damaged cardiac valves and cause infective endocarditis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1004540

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Sialoglycan microarray analysis of binding specificities of adhesin-BRs and corresponding whole bacteria. (A–C) Binding of the adhesin-BR proteins at 50 nM is presented. (n = 4, SD). (D) Adhesin-BR proteins and Cy3-labeled whole bacteria were assayed using the same sialoglycan microarrays. Heat map was generated using the method as previously described [29]. R1 and R2 represent two different spacers.
Figure 1 Sialoglycan microarray analysis of binding specificities of adhesin-BRs and corresponding whole bacteria. (A–C) Binding of the adhesin-BR proteins at 50 nM is presented. (n = 4, SD). (D) Adhesin-BR proteins and Cy3-labeled whole bacteria were assayed using the same sialoglycan microarrays. Heat map was generated using the method as previously described [29]. R1 and R2 represent two different spacers.CC BY · PubMed Central
Figure 2 Phylogeny of SRR glycoprotein BRs from a representative number of S. sanguinis and S. gordonii strains, and glycan binding to immobilized adhesin-BRs. (A) ClustalW2 was used for both the sequence alignment and the neighbor-joining tree reconstruction. Corresponding SRR adhesin-BR sequence accession numbers are provided in Table S3. (B) PAA-supported sTa binds to both the Hsa-BR and BRs of the four GspB-orthologues. (C) PAA-SLn only binds to Hsa-BR. (n = 6, SEM).
Figure 2 Phylogeny of SRR glycoprotein BRs from a representative number of S. sanguinis and S. gordonii strains, and glycan binding to immobilized adhesin-BRs. (A) ClustalW2 was used for both the sequence alignment and the neighbor-joining tree reconstruction. Corresponding SRR adhesin-BR sequence accession numbers are provided in Table S3. (B) PAA-supported sTa binds to both the Hsa-BR and BRs of the four GspB-orthologues. (C) PAA-SLn only binds to Hsa-BR. (n = 6, SEM).CC BY · PubMed Central
Figure 3 Bacterial binding to saliva and glycoconjugates, and bacterium-mediated hemagglutination. (A and B) Binding of DL1 vs. DL1Δhsa against immobilized whole human saliva, salivary ductal secretions, isolated and purified glycoproteins and related glycoconjugates, was tested by a dot blot assay. The binding was studied in the presence of EDTA (A) or divalent cations (B). (C–F) Bacterium-mediated hemagglutination using human RBCs and two-fold serial diluted bacterial suspensions. (C and D) DL1- and DL1Δhsa-mediated hemagglutination using non-sialidase treated (Ø) RBCs. (E and F) DL1- and DL1Δhsa-mediated hemagglutination using sialidase treated (S) RBCs.
Figure 3 Bacterial binding to saliva and glycoconjugates, and bacterium-mediated hemagglutination. (A and B) Binding of DL1 vs. DL1Δhsa against immobilized whole human saliva, salivary ductal secretions, isolated and purified glycoproteins and related glycoconjugates, was tested by a dot blot assay. The binding was studied in the presence of EDTA (A) or divalent cations (B). (C–F) Bacterium-mediated hemagglutination using human RBCs and two-fold serial diluted bacterial suspensions. (C and D) DL1- and DL1Δhsa-mediated hemagglutination using non-sialidase treated (Ø) RBCs. (E and F) DL1- and DL1Δhsa-mediated hemagglutination using sialidase treated (S) RBCs.CC BY · PubMed Central
Figure 4 Bacterial interactions with separated erythrocytes, platelets, and whole human plasma. (A) Wild type bacteria only hemagglutinate non-sialidase treated RBCs. Mutant strains do not show any hemagglutination. Bars represent median values. (n = 3). (B) Bacterial adhesion to fixed, immobilized platelets. (n = 6, SEM). (C) Whole plasma samples were immobilized on dot blot in three-fold serial dilutions starting from the original concentration in whole blood. Each strain was tested to interact with either non-sialidase treated (Ø) or sialidase treated whole plasma (S). *P<0.05, ***P<0.001.
Figure 4 Bacterial interactions with separated erythrocytes, platelets, and whole human plasma. (A) Wild type bacteria only hemagglutinate non-sialidase treated RBCs. Mutant strains do not show any hemagglutination. Bars represent median values. (n = 3). (B) Bacterial adhesion to fixed, immobilized platelets. (n = 6, SEM). (C) Whole plasma samples were immobilized on dot blot in three-fold serial dilutions starting from the original concentration in whole blood. Each strain was tested to interact with either non-sialidase treated (Ø) or sialidase treated whole plasma (S). *P<0.05, ***P<0.001.CC BY · PubMed Central
Figure 5 Representative flow cytometry profiles showing preferential platelet-bacterial adherence in intact whole human blood. (A–C) Whole blood (WB) in PBS. (D–F) Two antibodies, CD235a-FITC and CD41a-APC, were added to WB. (G–I) DL1-Cy3 incubated with CD235a-FITC and CD41a-APC: (G) DL1-Cy3 also appears in Q4 in the FSC/SSC plot, the same as platelets. (J–L) DL1-Cy3, CD235a-FITC and CD41a-APC were added to WB: (J) Platelets/bacteria are gated as R1 and RBCs/WBCs as R2. (K) Events from gate R1. (L) Events from gate R2. Bacteria preferentially recognize platelets compared to RBCs. (M–O) DL1Δhsa-Cy3, CD235a-FITC and CD41a-APC were added to WB: (N) Events from gate R3, and DL1Δhsa-Cy3 bound platelets are drastically reduced compared to DL1-Cy3 bound platelets. (O) Events from gate R4. Blood samples from multiple donors were tested and consistent results were obtained.
Figure 5 Representative flow cytometry profiles showing preferential platelet-bacterial adherence in intact whole human blood. (A–C) Whole blood (WB) in PBS. (D–F) Two antibodies, CD235a-FITC and CD41a-APC, were added to WB. (G–I) DL1-Cy3 incubated with CD235a-FITC and CD41a-APC: (G) DL1-Cy3 also appears in Q4 in the FSC/SSC plot, the same as platelets. (J–L) DL1-Cy3, CD235a-FITC and CD41a-APC were added to WB: (J) Platelets/bacteria are gated as R1 and RBCs/WBCs as R2. (K) Events from gate R1. (L) Events from gate R2. Bacteria preferentially recognize platelets compared to RBCs. (M–O) DL1Δhsa-Cy3, CD235a-FITC and CD41a-APC were added to WB: (N) Events from gate R3, and DL1Δhsa-Cy3 bound platelets are drastically reduced compared to DL1-Cy3 bound platelets. (O) Events from gate R4. Blood samples from multiple donors were tested and consistent results were obtained.CC BY · PubMed Central
Figure 6 Divalent cation effect on bacterial binding and preferential recognition of platelets over RBCs by Hsa-BR in whole blood. (A) DL1 and DL1Δhsa binding to either platelets or RBCs were comparable in EDTA- or heparin-anticoagulated whole blood. Bar values = 100×[number of bacterium-bound platelets (or RBCs)/total number of platelets (or RBCs)]. (n = 3, SEM). (B) Quantification and comparison of Hsa-BR binding to platelets and RBCs in whole blood. Bar values = 100×[number of HsaBR-bound platelets (or RBCs)/total number of platelets (or RBCs)]. (n = 6, SEM). (C) Q1 shows mainly RBCs, and Q4 platelets. Only 2° antibody, anti-GST-APC, alone was added in whole blood. (D–F) 6 to 96 pmol of Hsa-BR was added to whole blood, followed by anti-GST-APC. ****P<0.0001.
Figure 6 Divalent cation effect on bacterial binding and preferential recognition of platelets over RBCs by Hsa-BR in whole blood. (A) DL1 and DL1Δhsa binding to either platelets or RBCs were comparable in EDTA- or heparin-anticoagulated whole blood. Bar values = 100×[number of bacterium-bound platelets (or RBCs)/total number of platelets (or RBCs)]. (n = 3, SEM). (B) Quantification and comparison of Hsa-BR binding to platelets and RBCs in whole blood. Bar values = 100×[number of HsaBR-bound platelets (or RBCs)/total number of platelets (or RBCs)]. (n = 6, SEM). (C) Q1 shows mainly RBCs, and Q4 platelets. Only 2° antibody, anti-GST-APC, alone was added in whole blood. (D–F) 6 to 96 pmol of Hsa-BR was added to whole blood, followed by anti-GST-APC. ****P<0.0001.CC BY · PubMed Central
Figure 7 Blocking of DL1-platelet binding by Hsa-BR in whole human blood. (A) Representative FSC/SSC plot showing whole blood with added DL1-Cy3. Platelets and bacteria are gated as R1. (B–E) are gated from R1: (B) Whole blood with DL1-Cy3 and CD41a-APC. Non-DL1-bound platelets appear in Q1 and DL1-bound in Q2, while free DL1-Cy3 in Q3. (C–E) Whole blood with different concentrations of Hsa-BR added first, followed by DL1-Cy3 and CD41a-APC. Increasing amount of Hsa-BR results in decreasing count of DL1-bound platelets (Q2 percentages) and increasing numbers of free bacteria (Q3 percentages). (F) Quantification of Hsa-BR blocking of DL1 binding to platelets in whole blood. The percentage values of DL1-bound platelets were normalized, with the highest single value being 100%. (n = 6, SEM). *P<0.05, ***P<0.001.
Figure 7 Blocking of DL1-platelet binding by Hsa-BR in whole human blood. (A) Representative FSC/SSC plot showing whole blood with added DL1-Cy3. Platelets and bacteria are gated as R1. (B–E) are gated from R1: (B) Whole blood with DL1-Cy3 and CD41a-APC. Non-DL1-bound platelets appear in Q1 and DL1-bound in Q2, while free DL1-Cy3 in Q3. (C–E) Whole blood with different concentrations of Hsa-BR added first, followed by DL1-Cy3 and CD41a-APC. Increasing amount of Hsa-BR results in decreasing count of DL1-bound platelets (Q2 percentages) and increasing numbers of free bacteria (Q3 percentages). (F) Quantification of Hsa-BR blocking of DL1 binding to platelets in whole blood. The percentage values of DL1-bound platelets were normalized, with the highest single value being 100%. (n = 6, SEM). *P<0.05, ***P<0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 88

Metadata

Authors
Deng, L., Bensing, B. A., Thamadilok, S., Yu, H., Lau, K., Chen, X., Ruhl, S., Sullam, P. M., & Varki, A.
Affiliations
  • University of California San Diego (US)
  • San Francisco VA Medical Center (US)
  • University at Buffalo, State University of New York (US)
  • University of California, Davis (US)
Corresponding author
Varki, Ajit
Venue
PLoS Pathogens
Published
2014-12-04
Volume
10
Issue
12
Pages
e1004540
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W2102779260
Cited by
88
References
72
Citations by year
2026: 5 · 2025: 8 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 8 · 2019: 13 · 2018: 15 · 2017: 5 · 2016: 9 · 2015: 3
FWCI
2.33
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • U.S. Department of Veterans Affairs (I01 BX001653)
  • Northern California Institute for Research and Education
  • G. Harold and Leila Y. Mathers Foundation
  • National Institutes of Health (AI106987)
  • University of California, San Diego
  • National Heart, Lung, and Blood Institute (P01HL107150, NIH P01HL107150)
  • National Institute of Allergy and Infectious Diseases (R01-AI41513, R01AI106987, R01AI041513)
  • National Institute of Dental and Craniofacial Research (R01DE019807, DE019807, NIH/NIDCR DE019807)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD065122)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
Keywords
oral streptococci, infective endocarditis, Streptococcus viridans, sialic acid recognition, Streptococcus gordonii, Streptococcus sanguinis, HSA
MeSH terms
Blood Platelets, Endocarditis, Bacterial, Female, Humans, Male, Streptococcus sanguis, Adhesins, Bacterial, Virulence Factors, Protein Array Analysis, Streptococcus gordonii, Sialic Acid Binding Immunoglobulin-like Lectins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.